Canada is changing the recommendations for use of the Oxford-AstraZeneca COVID-19 vaccine.
The National Advisory Committee on Immunization says there is now enough evidence the vaccine is both safe and effective for seniors.
Prior to today's approval, the vaccine had not been recommended for use in those over the age of 65.
Currently in Manitoba, the eligibility criteria for the AstraZeneca vaccine includes those aged 50 to 64 at risk of severe outcomes and First Nations people 30 to 64 at risk of severe outcomes.
It is unclear at this time how the new approval will affect eligibility for the AstraZeneca vaccine in Manitoba.
